These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10773177)

  • 21. Indian study sparks debate on the use of placebo in psychiatry trials.
    Mudur G
    BMJ; 2006 Mar; 332(7541):566. PubMed ID: 16528065
    [No Abstract]   [Full Text] [Related]  

  • 22. Placebos, drug effects, and study design: a clinician's guide.
    Quitkin FM
    Am J Psychiatry; 1999 Jun; 156(6):829-36. PubMed ID: 10360119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebos in clinical practice and research.
    De Deyn PP; D'Hooge R
    J Med Ethics; 1996 Jun; 22(3):140-6. PubMed ID: 8798935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of placebos in clinical trials for acute schizophrenia.
    Addington D
    Can J Psychiatry; 1995 May; 40(4):171-6. PubMed ID: 7621385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of placebo controls in clinical trials disputed.
    Taubes G
    Science; 1995 Jan; 267(5194):25-6. PubMed ID: 7809605
    [No Abstract]   [Full Text] [Related]  

  • 26. Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression.
    Welge JA; Keck PE
    Psychopharmacology (Berl); 2003 Feb; 166(1):1-10. PubMed ID: 12494247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials: specific problems associated with the use of a placebo control group.
    Cleophas TJ; vd Meulen J; Kalmansohn RB
    Br J Clin Pharmacol; 1997 Mar; 43(3):219-21. PubMed ID: 9088576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are antipsychotic drugs the right treatment for challenging behaviour in learning disability?: The place of a randomised trial.
    Ashcroft R; Fraser B; Kerr M; Ahmed Z
    J Med Ethics; 2001 Oct; 27(5):338-43. PubMed ID: 11579192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M
    J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it ethical to use placebos in osteoporosis clinical trials?
    Watts NB
    Curr Rheumatol Rep; 2004 Feb; 6(1):79-84. PubMed ID: 14713406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo-controlled studies in depression: necessary, ethical and feasible.
    Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control].
    Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):541-7. PubMed ID: 15887064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials: specific problems associated with the use of a placebo-control group.
    Cleophas TJ
    J Mol Med (Berl); 1995 Aug; 73(8):421-4. PubMed ID: 8528745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations.
    Blease C; Colloca L; Kaptchuk TJ
    Bioethics; 2016 Jul; 30(6):407-14. PubMed ID: 26840547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia.
    Carpenter WT; Appelbaum PS; Levine RJ
    Am J Psychiatry; 2003 Feb; 160(2):356-62. PubMed ID: 12562584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the ethical acceptability of placebo application in neuropsychiatric research.
    De Deyn PP
    Acta Neurol Belg; 1995; 95(1):8-17. PubMed ID: 7725899
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?
    Emsley R; Fleischhacker WW
    Schizophr Res; 2013 Nov; 150(2-3):427-33. PubMed ID: 24094881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical and ethical considerations of sham operation].
    Antal J
    Magy Seb; 2007 Oct; 60(5):233-8. PubMed ID: 17984012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.